TGTX logo

TG Therapeutics (TGTX)

Profile

Full Name

TG Therapeutics, Inc.

Ticker Symbol

TGTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 3, 2010

Indexes

Not included

Website

http://www.tgtherapeutics.com

Employees

338

Key Details

Price

$36.71(+2.03%)

Market cap

$5.77B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$329.00M(+40.80% YoY)

Annual EPS

$0.15(+66.67% YoY)

PE ratio

262.21

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$36.71
TGTX price is $36.71

30-Day Relative Volume

0.58
TGTX 30-day relative volume is 0.58

Price Performance

Price Most recent change

+2.03%
TGTX price was up +2.03% on Apr 11, 2025

Price YTD change

+21.96%
TGTX price is up +21.96% since January 1st

Price 1-year change

+148.71%
TGTX price is up +148.71% year-on-year

Price 3-year change

+302.96%
TGTX price is up +302.96% over the past 3 years

Price Range

Price All-time high

$233.44
TGTX price is currently -84.27% below its historical high of $233.44

Price 3-year low

$3.48
TGTX price is currently +954.89% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.77B
TGTX market capitalization is $5.77 billion

Market cap 3-year change

+337.89%
TGTX market capitalization is up +337.89% over the past 3 years

Market cap All-time high

$7.63B
TGTX market capitalization is currently -24.46% below its historical high of $7.63 billion

Market cap sector rank

90.06%
TGTX market capitalization is higher than 90.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.62%
TGTX shares outstanding is up +1.62% year-on-year

Shares Outstanding 3-Year Change

+8.67%
TGTX shares outstanding is up +8.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
TGTX beta is 0.78

200-day SMA

$28.21
TGTX price is currently +30.12% above its 200-day simple moving average

50-day SMA

$35.64
TGTX price is currently +3.00% above its 50-day simple moving average

RSI

46.47
TGTX 14-day relative strength index is 46.47

Volume

0.58
TGTX 30-day relative volume is 0.58

ATR

$2.79
TGTX average true range is $2.79

10-day Historical Volatility

52.09%
TGTX 10-day historical volatility is 52.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$329.00M
TGTX annual revenue is $329.00 million

Revenue Analysts estimate

$553.55M
TGTX annual revenue is currently -40.57% lower than the consensus analysts' forecast

Revenue 1-year change

+40.8%
TGTX annual revenue is up +40.8% year-on-year

Revenue Sector rank

69.54%
TGTX annual revenue is higher than 69.54% of companies in Healthcare sector

EPS

EPS

$0.15
TGTX annual earnings per share is $0.15

EPS Analysts estimate

$1.05
TGTX annual earnings per share is currently -85.71% lower than the consensus analysts' forecast

EPS 1-year change

+66.67%
TGTX annual earnings per share is up +66.67% year-on-year

EPS Sector rank

84.23%
TGTX annual earnings per share is higher than 84.23% of companies in Healthcare sector

Profit

Gross profit

$290.52M
TGTX annual gross profit is $290.52 million

Gross margin

88.30%
TGTX annual gross profit margin is 88.30%

Operating profit

$41.93M
TGTX annual operating income is $41.93 million

Operating margin

12.74%
TGTX annual operating profit margin is 12.74%

Net income

$23.38M
TGTX annual net profit is $23.38 million

Net margin

7.11%
TGTX annual net profit margin is 7.11%

Expenses

Total expenses

$287.07M
TGTX annual total expenses is $287.07 million

Operating expenses

$248.59M
TGTX annual total operating expenses is $248.59 million

Cost of goods sold

$38.49M
TGTX annual cost of goods sold is $38.49 million

Selling, general & administrative expenses

$154.30M
TGTX annual SGA is $154.30 million

Depreciation and amortization

$280.00K
TGTX annual depreciation & amortization is $280.00 thousand

Interest expense

$24.03M
TGTX annual interest expense is $24.03 million

Income tax

$2.21M
TGTX annual income tax is $2.21 million

EBIT & EBITDA

EBIT

$49.62M
TGTX annual earnings before interest & taxes is $49.62 million

EBITDA

$49.90M
TGTX annual EBITDA is $49.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$577.69M
TGTX annual total assets is $577.69 million

Non current assets

$11.33M
TGTX annual long term assets is $11.33 million

Current assets

$566.36M
TGTX annual total current assets is $566.36 million

Cash and cash equivalents

$179.89M
TGTX annual cash & cash equivalents is $179.89 million

Accounts receivable

$129.19M
TGTX annual accounts receivable is $129.19 million

Inventory

$110.46M
TGTX annual inventory is $110.46 million

Liabilities

Total liabilities

$355.33M
TGTX annual total liabilities is $355.33 million

Long term liabilities

$264.65M
TGTX annual total long term liabilities is $264.65 million

Current liabilities

$90.68M
TGTX annual total current liabilities is $90.68 million

Accounts payable

-
TGTX annual accounts payable value is unknown

Debt

Total debt

$253.72M
TGTX annual total debt is $253.72 million

Total debt 1-year change

+129%
TGTX annual total debt is up +129% year-on-year

Long term debt

$252.56M
TGTX annual long term debt is $252.56 million

Short term debt

$1.16M
TGTX annual short term debt is $1.16 million

Equity & Capital

Shareholders equity

$222.36M
TGTX annual stockholders equity is $222.36 million

Book value

$222.36M
TGTX annual book value is $222.36 million

Retained earnings

-$1.53B
TGTX annual retained earnings is -$1.53 billion

Working capital

$475.68M
TGTX annual working capital is $475.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$40.52M
TGTX annual cash flow from operations is -$40.52 million

Cash from operations 1-year change

-28.98%
TGTX annual cash flow from operations is down -28.98% year-on-year

Cash from investing

-$1.04M
TGTX annual cash flow from investing activities is -$1.04 million

Cash from investing 1-year change

+97.95%
TGTX annual cash flow from investing activities is up +97.95% year-on-year

Cash from financing

$128.53M
TGTX annual cash flow from financing activities is $128.53 million

Cash from financing 1-year change

+76.78%
TGTX annual cash flow from financing activities is up +76.78% year-on-year

CAPEX

CAPEX

$45.00K
TGTX annual capital expenditures is $45.00 thousand

CAPEX 1-year change

-
TGTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$40.56M
TGTX annual free cash flow is -$40.56 million

Free cash flow 1-year change

-29.12%
TGTX annual free cash flow is down -29.12% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

88.30%
TGTX annual gross profit margin is 88.30%

Operating margin

12.74%
TGTX annual operating profit margin is 12.74%

Net margin

7.11%
TGTX annual net profit margin is 7.11%

ROA & ROE

ROA

5.15%
TGTX annual return on assets is 5.15%

ROE

12.21%
TGTX annual return on equity is 12.21%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

262.21
TGTX price to earnings ratio is 262.21

PE ratio Sector rank

96.55%
TGTX price to earnings ratio is higher than 96.55% of companies in Healthcare sector

PB Ratio

PB ratio

25.93
TGTX price to book ratio is 25.93

PB ratio Sector rank

97.37%
TGTX price to book ratio is higher than 97.37% of companies in Healthcare sector

PS Ratio

PS ratio

17.53
TGTX price to sales ratio is 17.53

PS ratio Sector rank

85.64%
TGTX price to sales ratio is higher than 85.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.84B
TGTX enterprise value is $5.84 billion

Enterprise value Sector rank

89.2%
TGTX enterprise value is higher than 89.2% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

116.72
TGTX EV/EBITDA is 116.72

EV/EBITDA Sector rank

98.78%
TGTX EV/EBITDA is higher than 98.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.25
TGTX annual current ratio is 6.25

Quick ratio

5.03
TGTX annual quick ratio is 5.03

Leverage

Debt to equity

1.10
TGTX annual debt to equity ratio is 1.10

Interest coverage ratio

2.07
TGTX annual interest coverage ratio is 2.07

Risk & Stability

Piotroski F-Score

4
TGTX piotroski f-score is 4

Altman Z-Score

7.87
TGTX altman z-score is 7.87

Analyst ratings

Recent major analysts updates

Mar 4, 25 HC Wainwright & Co.
Buy
Jan 15, 25 HC Wainwright & Co.
Buy
Nov 25, 24 JP Morgan
Overweight
Nov 5, 24 HC Wainwright & Co.
Buy
Nov 5, 24 Goldman Sachs
Neutral
Oct 29, 24 TD Cowen
Buy
Sep 18, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Goldman Sachs
Neutral
Aug 7, 24 B. Riley Securities
Buy
Aug 6, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

LEGN logo
Legend Biotech (LEGN)
BRKR logo
Bruker (BRKR)
Telix Pharmaceuticals Limited (TLX)
STVN logo
Stevanato Group SpA (STVN)
TFX logo
Teleflex Incorporated (TFX)
JAZZ logo
Jazz Pharmaceuticals (JAZZ)
MMSI logo
Merit Medical Systems (MMSI)
GH logo
Guardant Health (GH)
OPCH logo
Option Care Health (OPCH)
  • What is the ticker symbol for TG Therapeutics?
  • Does TG Therapeutics pay dividends?
  • What sector is TG Therapeutics in?
  • What industry is TG Therapeutics in?
  • What country is TG Therapeutics based in?
  • When did TG Therapeutics go public?
  • Is TG Therapeutics in the S&P 500?
  • Is TG Therapeutics in the NASDAQ 100?
  • Is TG Therapeutics in the Dow Jones?
  • When was TG Therapeutics's last earnings report?
  • When does TG Therapeutics report earnings?
  • Should I buy TG Therapeutics stock now?

What is the ticker symbol for TG Therapeutics?

The ticker symbol for TG Therapeutics is NASDAQ:TGTX

Does TG Therapeutics pay dividends?

No, TG Therapeutics does not pay dividends

What sector is TG Therapeutics in?

TG Therapeutics is in the Healthcare sector

What industry is TG Therapeutics in?

TG Therapeutics is in the Biotechnology industry

What country is TG Therapeutics based in?

TG Therapeutics is headquartered in United States

When did TG Therapeutics go public?

TG Therapeutics's initial public offering (IPO) was on May 3, 2010

Is TG Therapeutics in the S&P 500?

No, TG Therapeutics is not included in the S&P 500 index

Is TG Therapeutics in the NASDAQ 100?

No, TG Therapeutics is not included in the NASDAQ 100 index

Is TG Therapeutics in the Dow Jones?

No, TG Therapeutics is not included in the Dow Jones index

When was TG Therapeutics's last earnings report?

TG Therapeutics's most recent earnings report was on Mar 3, 2025

When does TG Therapeutics report earnings?

The next expected earnings date for TG Therapeutics is May 1, 2025

Should I buy TG Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page